<?xml version="1.0" encoding="UTF-8"?>
<p>Hexachlorophene, an antibacterial compound, was found to be effective for SFTSV in 
 <italic>in vitro</italic> screening using an FDA-approved drug library (Yuan et al., 
 <xref rid="B77" ref-type="bibr">2019</xref>). Because hexachlorophene can cause acute and subacute neurotoxicity in laboratory animals and humans (Kimbrough, 
 <xref rid="B31" ref-type="bibr">1973</xref>; Ramu et al., 
 <xref rid="B50" ref-type="bibr">2016</xref>), further 
 <italic>in vitro</italic> and 
 <italic>in vivo</italic> studies must be conducted.
</p>
